Symposia
- Date:
- Time: -
- Track: Clinical Practice
- CME/CE: 1
- Q & A: Chat
Sponsored by the Cardiovascular Diseases and Aging Special Interest Group
Moderator: Min Ji Kwak, MD, MS, DrPH
Management of atrial fibrillation (Afib) can be challenging in older adults due to co-existing complex multimorbidity causing therapeutic competition, polypharmacy and the socioeconomic burdens of aging. Learning Objectives: (1) review the epidemiology, diagnosis and pathophysiology of Afib; (2) acknowledge that Afib requires a multi-dimensional care strategy; (3) discuss the current evidence for pharmacologic and non-pharmacologic intervention for Afib; and (4) describe disparity and inequity issues in access to care for Afib as well as strategies to resolve these issues.
| Epidemiology of Afib Among Older Adults Inma Hernandez, PharmD, PhD |
| Atrial Fibrillation and Cognitive Impairment: Causation, Association, or an Epiphenomenon Ashok Krishnaswami, MD, MAS |
| Age-Friendly Pharmacologic Approach to Stroke Prevention in Afib Margaret C. Fang, MD, MPH |
| Age-Friendly Non-Pharmacologic Approach in Afib Management Larry R. Jackson II, MD, MHSc |